| Product NDC: | 0002-4464 |
| Proprietary Name: | Cialis |
| Non Proprietary Name: | Tadalafil |
| Active Ingredient(s): | 20 mg/1 & nbsp; Tadalafil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0002-4464 |
| Labeler Name: | Eli Lilly and Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021368 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20031126 |
| Package NDC: | 0002-4464-30 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (0002-4464-30) |
| NDC Code | 0002-4464-30 |
| Proprietary Name | Cialis |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (0002-4464-30) |
| Product NDC | 0002-4464 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tadalafil |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20031126 |
| Marketing Category Name | NDA |
| Labeler Name | Eli Lilly and Company |
| Substance Name | TADALAFIL |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |